References
- Therapeutic Guidelines. Cardiovascular chapter: Venous thromboembolism (VTE) treatment. 2024.
- Australian Commission on Safety and Quality in Health Care. Venous thromboembolism. In: Australian Commission on Safety and Quality in Health Care. 2018.
- Wells P, Anderson D. The diagnosis and treatment of venous thromboembolism. Hematology 2013;(1):457–63.
- White RH. The epidemiology of venous thromboembolism. Circulation 2003;107(23 Suppl 1):I4–8.
- Moheimani F, Jackson DE. Venous thromboembolism: classification, risk factors, diagnosis, and management. ISRN Hematol 2011;(1):124610.
- Access Economics. The burden of venous thromboembolism in Australia: report by access economics Pty Limited for The Australia and New Zealand working party on the management and prevention of venous thromboembolism. 2008.
- Anderson FA, Spencer FA. Risk factors for venous thromboembolism. Circulation. 2003;107(23 Suppl 1):I–9-I–16.
- Greenall R.Prevention, diagnosis and treatment of venous thromboembolism. Nurs Older People 2017;29(1):21–5.
- Lim W, Le Gal G, Bates SM, et al. American society of hematology 2018 guidelines for management of venous thromboembolism: diagnosis of venous thromboembolism. Blood Adv 2018;2(22):3226–56.
- Australian Commission on Safety and Quality in Health Care. Venous thromboembolism prevention clinical care standard. 2020. At: www.safetyandquality.gov.au/standards/clinical-care-standards/venous-thromboembolism-prevention-clinical-care-standard
- Badireddy M, Mudipalli VR. Deep venous thrombosis prophylaxis; 2024. At: www.ncbi.nlm.nih.gov/books/NBK534865/#:~:text=DVT%20prophylaxis%20can%20be%20primary,the%20treatment%20of%20subclinical%20DVT
- Paul JD, Cifu AS. Prevention and management of venous thromboembolism. JAMA. 2019;322(16):1602–3.
- Watson HG, Baglin TP. Guidelines on travel-related venous thrombosis. Br J Haematol 2011;152(1):31–4.
- Schreijer AJM, Cannegieter SC, Doggen CJM, et al. The effect of flight-related behaviour on the risk of venous thrombosis after air travel. British Journal of Haematology 2009;144(3):425–9.
- Clarke MJ, Broderick C, Hopewell S, et al. Compression stockings for preventing deep vein thrombosis in airline passengers. Cochrane Database of Systematic Reviews 2016. Issue 9.
- Philbrick JT, Shumate R, Siadaty MS, et al. Air travel and venous thromboembolism: a systematic review. J Gen Intern Med 2007;22(1):107–14.
- Gavish I, Brenner B. Air travel and the risk of thromboembolism. Intern Emerg Med 2011;6(2):113–6.
- Toff WD, Sugerman H, Eklöf BoG. Venous thrombosis related to air travel – reply. JAMA 2013;309(13):1347.
- Kearon C, Akl EA, Ornelas J, et al. Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report. Chest.2016;149(2):315–52.
- Nicolaides AN, Fareed J, Spyropoulos AC, et al. Prevention and management of venous thromboembolism. International consensus statement. Guidelines according to scientific evidence. Int Angiol 2024;43(1):1–222.
- Stevens H, Tran H, Gibbs H. Venous thromboembolism: current management. Aust Prescr 2019;42(4):123–6.
- Tran HA, Gibbs H, Merriman E, et al. New guidelines from the thrombosis and haemostasis society of Australia and New Zealand for the diagnosis and management of venous thromboembolism. Med J Aust 2019;210(5):227–35.
- Xarelto Product Information. eMIMSplus cloud 2024. At: www.emims.com.au/Australia/drug/search
- Eliquis Product Information. eMIMSplus cloud 2024. At: www.emims.com.au/Australia/drug/search
- Malik A, Ha NB, Barnes GD. Choice and duration of anticoagulation for venous thromboembolism. J Clin Med 2024;13(1):301.
- Khairani CD, Bejjani A, Piazza G, et al. Direct oral anticoagulants vs vitamin K antagonists in patients with antiphospholipid syndromes: meta-analysis of randomized trials. J Am Coll Cardiol 2023;81(1):16–30.
- Martin K, Beyer‐Westendorf J, Davidson BL, et al. Use of the direct oral anticoagulants in obese patients: guidance from the SSC of the ISTH. J Thromb and Haemost 2016;14(6):1308–13.
- Linnemann B, Beyer-Westendorf J, Espinola-Klein C, et al. Management of deep vein thrombosis: an update based on the revised AWMF S2k Guideline. Hamostaseologie 2024;44(2):97–110.
- Nieto JA, Bruscas MJ, Ruiz-Ribo D, et al. Acute venous thromboembolism in patients with recent major bleeding. The influence of the site of bleeding and the time elapsed on outcome. J Thromb Haemost 2006;4(11):2367–72.
- Klok FA, Huisman MV. How I assess and manage the risk of bleeding in patients treated for venous thromboembolism. Blood 2020;135(10):724–34.
- Khan F, Tritschler T, Kimpton M, et al. Long-term risk for major bleeding during extended oral anticoagulant therapy for first unprovoked venous thromboembolism: A systematic review and meta-analysis. Ann Intern Med 2021;174(10):1420–9.
- Horner T, Mahan CE. Venous thromboembolism: role of pharmacists and managed care considerations. Am J Manag Care 2017;23(20 Suppl):S391–8.
- Raskob GE, Angchaisuksiri P, Blanco AN, et al. Thrombosis: a major contributor to global disease burden. Semin Thromb Hemost 2014;40(7):724–35.